Uncategorized
Aerie Pharmaceuticals executive gives update on clinical trials in 2016
SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum here, Tom Mitro, president and COO of Aerie Pharmaceuticals, gives an update on the progress in clinical trials for both Rhopressa and Roclatan.